DSUVIA: payments to doctors
Payments that named DSUVIA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2M
- Providers
- 3,139
- Transactions
- 6,567
- Average per transaction
- $310
The per-transaction average — $310 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,139 providers the average total is $650, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acelrx Pharmaceuticals, Inc. | $2,033,438 | 99.7% |
| Vertical Pharmaceuticals, LLC | $5,302 | 0.3% |
| Tetraphase Pharmaceuticals, Inc. | $130 | 0.0% |
| Avion Pharmaceuticals | $80 | 0.0% |